The Profile of a Dedicated Company

1
The Profile of a Dedicated Company

• Audrey Schweitzer Director AltaCare
• Presentation at RHSC - October 2007

2
Corporate Presentation

• Founded in 1996 by two former executives from big
  pharma
• Self funded and still under control of founders
• Focused on Womens health and Adrenal diseases
• Sales of 30m in 2007, and market presence in 50
  countries
• Strong pipeline of new products especially in
  Womens health (contraception, uterine fibroid
  treatments, fertility regulation )
• AltaCare is a service company dedicated to
  enhancing international sales of its clients

3
Advocating by essence

• HRA Pharmas first product was the EC pill
  Norlevo
• The company has been at the forefront of the
  fight to enable access to EC
• Constant and successful effort to achieve OTC
  status for EC (Norlevo was granted OTC status in
  France as early as 1999)
• Overtime, HRA Pharma, with the help of AltaCare,
  have been fighting to introduce EC pill (Norlevo)
  in the private and public sectors of many
  difficult countries

4
A different pharma company

• Making products available to the poorest has been
  a corporate commitment since onset of the company
• A strong network has been built with NGOs active
  in the field of fertility regulation
• Making profit is second to ensuring access to EC
  besides the obvious absence of a profitable
  market
• Strong regulatory support and knowledge of local
  procedures

5
True actions

• Since 2001, more than dozen specific actions have
  been conducted, in connection with NGOs or alone,
  in more than 17 countries in order to
• Enable access to EC for the poorest (lower
  pricing, free supply, sustainability programs )
• Fight actively against social and political
  hurdles
• Understand behaviors
• In 2007, HRA Pharma has extended its scope of
  actions to its line of IUDs, enabling access in
  various Sub-Saharan countries through a
  partnership with French Ob/Gyn and a French NGO
• HRA has also developed and registered Gymiso, a
  misoprostol dedicated to medical TOP

6
Standing alone

• Actions are not conducted for a reward
• However, we believe that our commitment could
  have had a much greater impact if NGO support
  have been provided
• Please visit www.actionshrapharma.com which
  highlights the actions conducted by HRA Pharma
• At last, HRA Pharma is prepared to respond
  proactively and competitively to tenders for
  public markets

7
The next challenge

• Mifepristone went off-patent recently
• HRA Pharma a sister company dedicated to medical
  TOP
• HRA Pharma, and its CEO, André Ulmann, who have
  been at the inception of the product in 1990, are
  committed to make this essential drug widely
  available to women worldwide
• This challenge will not be achieved if a common
  goal is not set and open discussions,
  collaborations put in place between NGOs and
  pharmaceutical companies
• HRA Pharma has proven the strength of its
  commitment and is willing now to embark in this
  new challenge, together with the NGOs